Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Chan

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Psycho-Oncology|January 25, 2012
Being active or flexible? Role of control coping on quality of life among patients with gastrointestinal cancerCecilia Cheng, Nga-Yan Chan, Jasmine Hin-Man Chio, et al.
Journal of Gastroenterology and Hepatology|December 17, 2009
Epidemiology of colorectal cancer in AsiaYuk Kei Yee, Victoria P Y Tan, Pierre Chan, et al.
Cancer|December 25, 2008
Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor responseThomas Yau, Pierre Chan, Kelvin K Ng, et al.
Investigational New Drugs|March 10, 2012
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory diseaseThomas Yau, Hilda Wong, Pierre Chan, et al.
Investigational New Drugs|March 20, 2012
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinomaThomas Yau, P N Cheng, Pierre Chan, et al.
Investigational New Drugs|February 11, 2015
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinomaThomas Yau, Paul N Cheng, Pierre Chan, et al.
Journal of Evaluation in Clinical Practice|August 20, 2011
Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasmCarlos K H Wong, Cindy L K Lam, Wai-Lun Law, et al.
Journal of Gastroenterology and Hepatology|January 16, 2010
Trend of colorectal cancer in Hong Kong: 1983-2006Yuk Kei Yee, Qing Gu, Ivan Hung, et al.
Journal of Gastroenterology|May 4, 2011
Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trialVictoria P Y Tan, Wai M Wong, Ting K Cheung, et al.
Journal of Evaluation in Clinical Practice|November 25, 2011
Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspectiveCarlos K H Wong, Cindy L K Lam, Jensen T C Poon, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Psycho-Oncology|January 25, 2012
Being active or flexible? Role of control coping on quality of life among patients with gastrointestinal cancerCecilia Cheng, Nga-Yan Chan, Jasmine Hin-Man Chio, et al.
Journal of Gastroenterology and Hepatology|December 17, 2009
Epidemiology of colorectal cancer in AsiaYuk Kei Yee, Victoria P Y Tan, Pierre Chan, et al.
Cancer|December 25, 2008
Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor responseThomas Yau, Pierre Chan, Kelvin K Ng, et al.
Investigational New Drugs|March 10, 2012
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory diseaseThomas Yau, Hilda Wong, Pierre Chan, et al.
Investigational New Drugs|March 20, 2012
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinomaThomas Yau, P N Cheng, Pierre Chan, et al.
Investigational New Drugs|February 11, 2015
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinomaThomas Yau, Paul N Cheng, Pierre Chan, et al.
Journal of Evaluation in Clinical Practice|August 20, 2011
Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasmCarlos K H Wong, Cindy L K Lam, Wai-Lun Law, et al.
Journal of Gastroenterology and Hepatology|January 16, 2010
Trend of colorectal cancer in Hong Kong: 1983-2006Yuk Kei Yee, Qing Gu, Ivan Hung, et al.
Journal of Gastroenterology|May 4, 2011
Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trialVictoria P Y Tan, Wai M Wong, Ting K Cheung, et al.
Journal of Evaluation in Clinical Practice|November 25, 2011
Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspectiveCarlos K H Wong, Cindy L K Lam, Jensen T C Poon, et al.
Pageof 4